{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T17:38:12Z","timestamp":1787593092847,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,24]]},"DOI":"10.7759\/cureus.115096","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T17:15:03Z","timestamp":1787591703000},"source":"Crossref","is-referenced-by-count":0,"title":["Resolution of Osteoporosis in a Breast Cancer Survivor Following Supervised Osteogenic Loading and High-Adherence Lifestyle Modification: A Case Report"],"prefix":"10.7759","author":[{"given":"Youssef","family":"Salama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahla","family":"Heikal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-021-05900-y","article-title":"The clinician's guide to prevention and treatment of osteoporosis","volume":"33","author":"LeBoff MS","year":"2022","unstructured":"LeBoff MS, Greenspan SL, Insogna KL, Lewiecki EM, Saag KG, Singer AJ, Siris ES. The clinician's guide to prevention and treatment of osteoporosis. Osteoporos Int. 2022, 33:2049-102. 10.1007\/s00198-021-05900-y","journal-title":"Osteoporos Int"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2022.101754","article-title":"Osteoporosis in 2022: care gaps to screening and personalised medicine","volume":"36","author":"Curtis EM","year":"2022","unstructured":"Curtis EM, Dennison EM, Cooper C, Harvey NC. Osteoporosis in 2022: care gaps to screening and personalised medicine. Best Pract Res Clin Rheumatol. 2022, 36:101754. 10.1016\/j.berh.2022.101754","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.534","article-title":"Bone mineral density loss in relation to the final menstrual period in a multiethnic cohort: results from the Study of Women's Health Across the Nation (SWAN)","volume":"27","author":"Greendale GA","year":"2012","unstructured":"Greendale GA, Sowers M, Han W, et al.. Bone mineral density loss in relation to the final menstrual period in a multiethnic cohort: results from the Study of Women's Health Across the Nation (SWAN). J Bone Miner Res. 2012, 27:111-8. 10.1002\/jbmr.534","journal-title":"J Bone Miner Res"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1080\/13697137.2023.2258783","article-title":"The 2023 practitioner\u2019s toolkit for managing menopause","volume":"26","author":"Davis SR","year":"2023","unstructured":"Davis SR, Taylor S, Hemachandra C, Magraith K, Ebeling PR, Jane F, Islam RM. The 2023 practitioner\u2019s toolkit for managing menopause. Climacteric. 2023, 26:517-36. 10.1080\/13697137.2023.2258783","journal-title":"Climacteric"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2024.27154","article-title":"US Preventive Services Task Force. Screening for osteoporosis to prevent fractures: US Preventive Services Task Force recommendation statement","volume":"333","author":"Nicholson WK","year":"2025","unstructured":"Nicholson WK, Silverstein M, Wong JB, et al.. US Preventive Services Task Force. Screening for osteoporosis to prevent fractures: US Preventive Services Task Force recommendation statement. JAMA. 2025, 333:498-508. 10.1001\/jama.2024.27154","journal-title":"JAMA"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.040508","article-title":"Predictive value of low BMD for 1-year fracture outcomes is similar for postmenopausal women ages 50-64 and 65 and older: results from the National Osteoporosis Risk Assessment (NORA)","volume":"19","author":"Siris ES","year":"2004","unstructured":"Siris ES, Brenneman SK, Miller PD, Barrett-Connor E, Chen YT, Sherwood LM, Abbott TA. Predictive value of low BMD for 1-year fracture outcomes is similar for postmenopausal women ages 50-64 and 65 and older: results from the National Osteoporosis Risk Assessment (NORA). J Bone Miner Res. 2004, 19:1215-20. 10.1359\/JBMR.040508","journal-title":"J Bone Miner Res"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s11657-023-01231-z","article-title":"Cytotoxic chemotherapy is associated with decreased bone mineral density in postmenopausal women with early and locally advanced breast cancer","volume":"18","author":"Nisha Y","year":"2023","unstructured":"Nisha Y, Dubashi B, Bobby Z, Sahoo JP, Kayal S, Ananthakrishnan R, Ganesan P. Cytotoxic chemotherapy is associated with decreased bone mineral density in postmenopausal women with early and locally advanced breast cancer. Arch Osteoporos. 2023, 18:41. 10.1007\/s11657-023-01231-z","journal-title":"Arch Osteoporos"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.soncn.2022.151273","article-title":"Bone health considerations in breast cancer","volume":"38","author":"Fessele KL","year":"2022","unstructured":"Fessele KL. Bone health considerations in breast cancer. Semin Oncol Nurs. 2022, 38:151273. 10.1016\/j.soncn.2022.151273","journal-title":"Semin Oncol Nurs"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1236188","article-title":"Association between tamoxifen and incidence of osteoporosis in Korean patients with ductal carcinoma in situ","volume":"13","author":"Kim D","year":"2023","unstructured":"Kim D, Oh J, Lee HS, Jeon S, Park WC, Yoon CI. Association between tamoxifen and incidence of osteoporosis in Korean patients with ductal carcinoma in situ. Front Oncol. 2023, 13:1236188. 10.3389\/fonc.2023.1236188","journal-title":"Front Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s12282-024-01586-2","article-title":"Adverse effects of tamoxifen treatment on bone mineral density in premenopausal patients with breast cancer: a systematic review and meta-analysis","volume":"31","author":"Lee SJ","year":"2024","unstructured":"Lee SJ, Cha CD, Hong H, Choi YY, Chung MS. Adverse effects of tamoxifen treatment on bone mineral density in premenopausal patients with breast cancer: a systematic review and meta-analysis. Breast Cancer. 2024, 31:717-25. 10.1007\/s12282-024-01586-2","journal-title":"Breast Cancer"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.02.3515","article-title":"Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status","volume":"24","author":"Vehmanen L","year":"2006","unstructured":"Vehmanen L, Elomaa I, Blomqvist C, Saarto T. Tamoxifen treatment after adjuvant chemotherapy has opposite effects on bone mineral density in premenopausal patients depending on menstrual status. J Clin Oncol. 2006, 24:675-80. 10.1200\/JCO.2005.02.3515","journal-title":"J Clin Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.01696","article-title":"Management of osteoporosis in survivors of adult cancers with nonmetastatic disease: ASCO Clinical Practice Guideline","volume":"37","author":"Shapiro CL","year":"2019","unstructured":"Shapiro CL, Van Poznak C, Lacchetti C, et al.. Management of osteoporosis in survivors of adult cancers with nonmetastatic disease: ASCO Clinical Practice Guideline. J Clin Oncol. 2019, 37:2916-46. 10.1200\/JCO.19.01696","journal-title":"J Clin Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1172\/JCI11066","article-title":"Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha","volume":"106","author":"Cenci S","year":"2000","unstructured":"Cenci S, Weitzmann MN, Roggia C, Namba N, Novack D, Woodring J, Pacifici R. Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha. J Clin Invest. 2000, 106:1229-37. 10.1172\/JCI11066","journal-title":"J Clin Invest"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1172\/JCI28550","article-title":"Estrogen deficiency and bone loss: an inflammatory tale","volume":"116","author":"Weitzmann MN","year":"2006","unstructured":"Weitzmann MN, Pacifici R. Estrogen deficiency and bone loss: an inflammatory tale. J Clin Invest. 2006, 116:1186-94. 10.1172\/JCI28550","journal-title":"J Clin Invest"},{"key":"ref15","unstructured":"FRAX. (2026). Accessed. August 21, 2026: https:\/\/www.fraxplus.org\/."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-081250","article-title":"Advances in the management of osteoporosis","volume":"390","author":"Hoong CW","year":"2025","unstructured":"Hoong CW, Saul D, Khosla S, Sfeir JG. Advances in the management of osteoporosis. BMJ. 2025, 390:e081250. 10.1136\/bmj-2024-081250","journal-title":"BMJ"},{"key":"ref17","article-title":"ACR-ISCD-SSR Practice Parameter for the Performance of Dual-Energy X-ray Absorptiometry (DXA)","author":"American College of Radiology","year":"2018","unstructured":"American College of Radiology. ACR-ISCD-SSR Practice Parameter for the Performance of Dual-Energy X-ray Absorptiometry (DXA). American College of Radiology, Reston, VA; 2018."},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jocd.2019.04.001","article-title":"Bone mineral density precision for individual and combined vertebrae configurations from lumbar spine dual-energy X-ray absorptiometry scans","volume":"23","author":"Hind K","year":"2020","unstructured":"Hind K, Oldroyd B. Bone mineral density precision for individual and combined vertebrae configurations from lumbar spine dual-energy X-ray absorptiometry scans. J Clin Densitom. 2020, 23:673-7. 10.1016\/j.jocd.2019.04.001","journal-title":"J Clin Densitom"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3996","article-title":"T-score as an indicator of fracture risk during treatment with romosozumab or alendronate in the ARCH trial","volume":"35","author":"Cosman F","year":"2020","unstructured":"Cosman F, Lewiecki EM, Ebeling PR, et al.. T-score as an indicator of fracture risk during treatment with romosozumab or alendronate in the ARCH trial. J Bone Miner Res. 2020, 35:1333-42. 10.1002\/jbmr.3996","journal-title":"J Bone Miner Res"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.2151","article-title":"Can change in FRAX score be used to \"treat to target\"? A population\u2010based cohort study","volume":"29","author":"Leslie WD","year":"2014","unstructured":"Leslie WD, Majumdar SR, Lix LM, et al.. Can change in FRAX score be used to \"treat to target\"? A population\u2010based cohort study. J Bone Miner Res. 2014, 29:1074-80. 10.1002\/jbmr.2151","journal-title":"J Bone Miner Res"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9343(01)01124-x","article-title":"Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs","volume":"112","author":"Cummings SR","year":"2002","unstructured":"Cummings SR, Karpf DB, Harris F, et al.. Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. Am J Med. 2002, 112:281-289. 10.1016\/s0002-9343(01)01124-x","journal-title":"Am J Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/ajpa.20371","article-title":"Who's afraid of the big bad Wolff?: \"Wolff's law\" and bone functional adaptation","volume":"129","author":"Ruff C","year":"2006","unstructured":"Ruff C, Holt B, Trinkaus E. Who's afraid of the big bad Wolff?: \"Wolff's law\" and bone functional adaptation. Am J Phys Anthropol. 2006, 129:484-98. 10.1002\/ajpa.20371","journal-title":"Am J Phys Anthropol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaf077","article-title":"Brief, low-impact, high-intensity osteogenic loading in postmenopausal osteoporosis: a quasi-experimental case-series study","volume":"110","author":"Papadopoulou-Marketou N","year":"2025","unstructured":"Papadopoulou-Marketou N, Papageorgiou A, Marketos N, Tsiamyrtzis P, Vavetsis G, Chrousos GP. Brief, low-impact, high-intensity osteogenic loading in postmenopausal osteoporosis: a quasi-experimental case-series study. J Clin Endocrinol Metab. 2025, 110:e2878-87. 10.1210\/clinem\/dgaf077","journal-title":"J Clin Endocrinol Metab"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.4172\/2329-9509.1000146","article-title":"Axial bone osteogenic loading-type resistance therapy showing BMD and functional bone performance musculoskeletal adaptation over 24 weeks with postmenopausal female subjects","volume":"3","author":"Hunte B","year":"2015","unstructured":"Hunte B, Jaquish J, Huck C. Axial bone osteogenic loading-type resistance therapy showing BMD and functional bone performance musculoskeletal adaptation over 24 weeks with postmenopausal female subjects. J Osteoporos Phys Act. 2015, 3:146. 10.4172\/2329-9509.1000146","journal-title":"J Osteoporos Phys Act"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/s13018-025-05890-1","article-title":"Optimal resistance training parameters for improving bone mineral density in postmenopausal women: a systematic review and meta-analysis","volume":"20","author":"Zhao F","year":"2025","unstructured":"Zhao F, Su W, Sun Y, Wang J, Lu B, Yun H. Optimal resistance training parameters for improving bone mineral density in postmenopausal women: a systematic review and meta-analysis. J Orthop Surg Res. 2025, 20:523. 10.1186\/s13018-025-05890-1","journal-title":"J Orthop Surg Res"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyw142","article-title":"Exercise interventions and prevention of fall-related fractures in older people: a meta-analysis of randomized controlled trials","volume":"46","author":"Zhao R","year":"2017","unstructured":"Zhao R, Feng F, Wang X. Exercise interventions and prevention of fall-related fractures in older people: a meta-analysis of randomized controlled trials. Int J Epidemiol. 2017, 46:149-61. 10.1093\/ije\/dyw142","journal-title":"Int J Epidemiol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjpt.2018.11.011","article-title":"Exercise for the prevention of osteoporosis in postmenopausal women: an evidence-based guide to the optimal prescription","volume":"23","author":"Daly RM","year":"2019","unstructured":"Daly RM, Dalla Via J, Duckham RL, Fraser SF, Helge EW. Exercise for the prevention of osteoporosis in postmenopausal women: an evidence-based guide to the optimal prescription. Braz J Phys Ther. 2019, 23:170-80. 10.1016\/j.bjpt.2018.11.011","journal-title":"Braz J Phys Ther"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.4158\/GL-2020-0524SUPPL","article-title":"AACE\/ACE Postmenopausal Osteoporosis Guidelines Task Force. American Association of Clinical Endocrinologists\/American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis\u20142020 update","volume":"26","author":"Camacho PM","year":"2020","unstructured":"Camacho PM, Petak SM, Binkley N, et al.. AACE\/ACE Postmenopausal Osteoporosis Guidelines Task Force. American Association of Clinical Endocrinologists\/American College of Endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal osteoporosis\u20142020 update. Endocr Pract. 2020, 26:1-46. 10.4158\/GL-2020-0524SUPPL","journal-title":"Endocr Pract"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1016\/j.advnut.2023.03.007","article-title":"Commonalities among dietary recommendations from 2010 to 2021 clinical practice guidelines: a meta-epidemiological study from the American College of Lifestyle Medicine","volume":"14","author":"Cara KC","year":"2023","unstructured":"Cara KC, Goldman DM, Kollman BK, Amato SS, Tull MD, Karlsen MC. Commonalities among dietary recommendations from 2010 to 2021 clinical practice guidelines: a meta-epidemiological study from the American College of Lifestyle Medicine. Adv Nutr. 2023, 14:500-15. 10.1016\/j.advnut.2023.03.007","journal-title":"Adv Nutr"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab492","article-title":"The association of gut microbiota with osteoporosis is mediated by amino acid metabolism: multiomics in a large cohort","volume":"106","author":"Ling CW","year":"2021","unstructured":"Ling CW, Miao Z, Xiao ML, et al.. The association of gut microbiota with osteoporosis is mediated by amino acid metabolism: multiomics in a large cohort. J Clin Endocrinol Metab. 2021, 106:e3852-64. 10.1210\/clinem\/dgab492","journal-title":"J Clin Endocrinol Metab"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1186892","article-title":"Regulation of short-chain fatty acids in the immune system","volume":"14","author":"Liu XF","year":"2023","unstructured":"Liu XF, Shao JH, Liao YT, et al.. Regulation of short-chain fatty acids in the immune system. Front Immunol. 2023, 14:1186892. 10.3389\/fimmu.2023.1186892","journal-title":"Front Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/520446-resolution-of-osteoporosis-in-a-breast-cancer-survivor-following-supervised-osteogenic-loading-and-high-adherence-lifestyle-modification-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T17:15:04Z","timestamp":1787591704000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/520446-resolution-of-osteoporosis-in-a-breast-cancer-survivor-following-supervised-osteogenic-loading-and-high-adherence-lifestyle-modification-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,24]]},"references-count":31,"URL":"https:\/\/doi.org\/10.7759\/cureus.115096","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8,24]]}}}